Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2000
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071129A1 Pyrrolotriazine inhibitors of kinases
11/30/2000WO2000071127A1 Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
11/30/2000WO2000071118A1 Phospholipase a2-specific inhibiting compounds
11/30/2000WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000046199A3 Indole derivatives as anti-inflammation agents
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000041692A3 Compositions having improved stability
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2375543A1 Salts of cis-¬4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate|
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374550A1 Antigenic neisserial peptides
11/30/2000CA2374520A1 Secreted alpha-helical protein - 32
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/30/2000CA2373992A1 Medicinal compositions containing anti-fas antibody
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373588A1 Gene therapy of pulmonary disease
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054685A1 Liquid crystal forms of cyclosporin
11/29/2000EP1054678A2 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
11/29/2000EP1054667A1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
11/29/2000EP1054664A1 Method for modulating macrophage activation
11/29/2000EP0863905B1 imidazole lipoxygenase inhibitors
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1274603A Externally-used arthralgia treating medicine and its preparation
11/29/2000CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism
11/29/2000CN1058965C New thiophene compounds, process for their preparation and pharmaceutical compositions containing them
11/28/2000US6153736 Modified ether glyceroglycolipids
11/28/2000US6153655 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/28/2000US6153650 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage.
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153225 Injectable formulations of nanoparticulate naproxen
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2046308C Radiolabeled colloid compositions, their use and process for their preparation
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070060A1 Production of complex carbohydrates
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069868A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069844A1 Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors
11/23/2000WO2000069843A2 Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives
11/23/2000WO2000069842A1 Benzofuranylsulfonates
1 ... 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 ... 1272